22.29

0.84% 0.205

Elanco Animal Health Inc (ELAN)

Overview News Price History Option Chain Financials Discussions Forecast

Elanco Animal Health Inc stock is traded at $22.29, with a volume of 1.30M. It is up +0.84% in the last 24 hours and up +4.09% over the past month. Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Previous Close:

$22.08

Open:

$22.3

24h Volume:

1.30M

Relative Volume:

0.24

Market Cap:

$11.07B

Revenue:

$4.45B

Net Income/Loss:

$205.00M

P/E Ratio:

55.71

EPS:

0.4

Net Cash Flow:

$372.00M

1W Performance:

+4.68%

1M Performance:

+4.09%

6M Performance:

+67.03%

1Y Performance:

+89.81%

1-Day Range:

$22.16

$22.69

1-Week Range:

$20.96

$22.69

52-Week Range:

$8.02

$23.70

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name

Elanco Animal Health Inc

Sector

Healthcare (1136)

Industry

Drug Manufacturers - Specialty & Generic (85)

Phone

877-352-6261

Address

450 ELANCO CIRCLE, INDIANAPOLIS

Employee

9,450

Twitter

@Elanco

Next Earnings Date

2024-11-07

Latest SEC Filings

ELAN's Discussions on Twitter

Compare ELAN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ELAN Elanco Animal Health Inc	22.28	10.97B	4.45B	205.00M	372.00M	0.40
ZTS Zoetis Inc	123.72	53.87B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	14.86	45.71B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.885	43.73B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	29.98	34.49B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	509.07	22.00B	3.08B	1.24B	1.07B	25.61

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-09-25	Initiated	Barclays	Overweight
Nov-21-25	Initiated	KeyBanc Capital Markets	Overweight
Nov-19-25	Upgrade	Argus	Hold → Buy
Oct-07-25	Upgrade	JP Morgan	Neutral → Overweight
Jul-17-25	Upgrade	Leerink Partners	Market Perform → Outperform
Jun-26-25	Upgrade	William Blair	Mkt Perform → Outperform
Dec-09-24	Initiated	UBS	Buy
Dec-02-24	Initiated	Leerink Partners	Market Perform
Sep-19-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-05-24	Upgrade	Stifel	Hold → Buy
Dec-19-23	Initiated	Jefferies	Buy
Dec-15-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Dec-07-23	Initiated	Exane BNP Paribas	Outperform
Apr-20-23	Upgrade	Barclays	Equal Weight → Overweight
Aug-18-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-16-22	Downgrade	JP Morgan	Overweight → Neutral
Jul-21-22	Downgrade	Goldman	Buy → Sell
Jul-12-22	Initiated	Piper Sandler	Neutral
Nov-18-21	Initiated	Morgan Stanley	Overweight
Oct-28-21	Downgrade	Stifel	Buy → Hold
Aug-05-21	Resumed	Credit Suisse	Outperform
Jun-15-21	Upgrade	Cleveland Research	Underperform → Neutral
May-11-21	Upgrade	Barclays	Underweight → Equal Weight
May-11-21	Upgrade	Gabelli & Co	Hold → Buy
Apr-15-21	Initiated	Stifel	Buy
Mar-22-21	Downgrade	Gabelli & Co	Buy → Hold
Feb-26-21	Upgrade	Credit Suisse	Neutral → Outperform
Dec-09-20	Downgrade	Argus	Buy → Hold
Nov-09-20	Downgrade	Barclays	Overweight → Underweight
Aug-20-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-13-20	Resumed	Credit Suisse	Neutral
Aug-04-20	Resumed	Goldman	Buy
Jul-27-20	Downgrade	Cleveland Research	Neutral → Underperform
Apr-02-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-10-20	Initiated	Raymond James	Mkt Perform
Dec-19-19	Upgrade	BofA/Merrill	Neutral → Buy
Nov-07-19	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-23-19	Initiated	Barclays	Overweight
Aug-26-19	Downgrade	BofA/Merrill	Buy → Neutral
Aug-15-19	Upgrade	UBS	Sell → Neutral
May-23-19	Initiated	Guggenheim	Neutral
Mar-18-19	Upgrade	BofA/Merrill	Neutral → Buy
Mar-13-19	Resumed	Morgan Stanley	Equal-Weight
Feb-12-19	Initiated	William Blair	Mkt Perform
Jan-23-19	Initiated	UBS	Sell
Jan-15-19	Initiated	Argus	Buy
Oct-15-18	Initiated	Morgan Stanley	Equal-Weight

View All

Elanco Animal Health Inc Stock (ELAN) Latest News

09:06 AM

FDA conditionally approves Elanco’s treatment for screwworm in dogs By Investing.com - Investing.com Australia

09:06 AM

FDA conditionally approves Elanco’s treatment for screwworm in dogs - Investing.com India

09:06 AM

08:43 AM

Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs - PR Newswire

08:43 AM

08:02 AM

Jim Cramer Praises Elanco Animal Health: 'They've Turned That Company Around' - Benzinga

08:02 AM

Dec 17, 2025

Elanco (ELAN): Valuation Check After Insider Buying Spree and New Restructuring Plan - Yahoo Finance

Dec 17, 2025

Dec 16, 2025

Elanco Animal Health Director Purchases 10,000 Shares - TradingView — Track All Markets

Dec 16, 2025

[Form 4] Elanco Animal Health Inc Insider Trading Activity - Stock Titan

Dec 16, 2025